ijms-logo

Journal Browser

Journal Browser

Biomolecules in the Treatment of Biofilm-Related Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 July 2024 | Viewed by 3277

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Diagnostics, Medical College, Jagiellonian University, 31-688 Kraków, Poland
Interests: metabolic activity of the brain's diseases like neuropsychiatric, stroke; redox signaling, tooth decay, biostatistics, biomaterials; composites; drug delivery systems
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues, 

Biofilms are adhesive macrostructures build by various microorganisms together with produced by them extracellular matrix. The high adaptability of the biofilm and its feature of being an excellent physical barrier are associated with the resistance of microorganisms arranged in it to classical treatment regimens. Studies on classic antimicrobial agents such as antibiotics and disinfectants indicate that microorganisms enclosed in a biofilm are 10 to 1000 times more resistant to their action compared to planktonic form of the same microorganism. This poses a challenge to conventionally used antimicrobials and indicates the need for developing new therapies. Newly developed strategies to combat biofilms on one hand should effectively break the biofilm barrier, on the other, overcome gradually increasing resistance mechanisms, by interfering with new molecular targets.

In this issue, we would like to take up the topic of natural origin substances, which can provide therapy targeted on treatment of biofilm related diseases by interfering with biofilm formation on all stages of this process. The topic of interest includes, but is not limited to: antimicrobial peptides, enzymes, natural-origin small molecules as well as biologically active nanomaterials.

Dr. Wirginia Krzyściak
Prof. Dr. Elżbieta Pamuła
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • biofilms
  • biomolecules
  • antimicrobial peptides
  • small molecules
  • antimicrobial enzymes
  • bionanomaterials

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

18 pages, 2459 KiB  
Article
Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
by Marcin Magacz, Sergio Alatorre-Santamaría, Karolina Kędziora, Kacper Klasa, Paweł Mamica, Wiktoria Pepasińska, Magdalena Lebiecka, Dorota Kościelniak, Elżbieta Pamuła and Wirginia Krzyściak
Int. J. Mol. Sci. 2023, 24(15), 12136; https://doi.org/10.3390/ijms241512136 - 28 Jul 2023
Cited by 1 | Viewed by 1459
Abstract
The lactoperoxidase (LPO) system shows promise in the prevention of dental caries, a common chronic disease. This system has antimicrobial properties and is part of the non-specific antimicrobial immune system. Understanding the efficacy of the LPO system in the fight against biofilms could [...] Read more.
The lactoperoxidase (LPO) system shows promise in the prevention of dental caries, a common chronic disease. This system has antimicrobial properties and is part of the non-specific antimicrobial immune system. Understanding the efficacy of the LPO system in the fight against biofilms could provide information on alternative strategies for the prevention and treatment of caries. In this study, the enzymatic system was modified using four different (pseudo)halide substrates (thiocyanate, thiocyanate-iodide mixture, selenocyanate, and iodide). The study evaluated the metabolic effects of applying such modifications to Streptococcus mutans; in particular: (1) biofilm formation, (2) synthesis of insoluble polysaccharides, (3) lactate synthesis, (4) glucose and sucrose consumption, (5) intracellular NAD+ and NADH concentrations, and (6) transmembrane glucose transport efficiency (PTS activity). The results showed that the LPO–iodide system had the strongest inhibitory effect on biofilm growth and lactate synthesis (complete inhibition). This was associated with an increase in the NAD+/NADH ratio and an inhibition of glucose PTS activity. The LPO–selenocyanate system showed a moderate inhibitory effect on biofilm biomass growth and lactate synthesis. The other systems showed relatively small inhibition of lactate synthesis and glucose PTS but no effect on the growth of biofilm biomass. This study provides a basis for further research on the use of alternative substrates with the LPO system, particularly the LPO–iodide system, in the prevention and control of biofilm-related diseases. Full article
(This article belongs to the Special Issue Biomolecules in the Treatment of Biofilm-Related Diseases)
Show Figures

Figure 1

14 pages, 2972 KiB  
Communication
Cm-p5 Peptide Dimers Inhibit Biofilms of Candida albicans Clinical Isolates, C. parapsilosis and Fluconazole-Resistant Mutants of C. auris
by Valerie Amann, Ann-Kathrin Kissmann, Vanessa Mildenberger, Imke Krebs, Julio A. Perez-Erviti, Ernesto M. Martell-Huguet, Anselmo J. Otero-Gonzalez, Fidel Morales-Vicente, Gina P. Rodríguez-Castaño, Carolina Firacative, Armando Rodríguez, Ludger Ständker, Tanja Weil, Barbara Spellerberg, Steffen Stenger and Frank Rosenau
Int. J. Mol. Sci. 2023, 24(12), 9788; https://doi.org/10.3390/ijms24129788 - 06 Jun 2023
Cited by 2 | Viewed by 1363
Abstract
Antimicrobial peptides (AMPs) represent a promising class of therapeutic biomolecules that show antimicrobial activity against a broad range of microorganisms, including life-threatening pathogens. In contrast to classic AMPs with membrane-disrupting activities, new peptides with a specific anti-biofilm effect are gaining in importance since [...] Read more.
Antimicrobial peptides (AMPs) represent a promising class of therapeutic biomolecules that show antimicrobial activity against a broad range of microorganisms, including life-threatening pathogens. In contrast to classic AMPs with membrane-disrupting activities, new peptides with a specific anti-biofilm effect are gaining in importance since biofilms could be the most important way of life, especially for pathogens, as the interaction with host tissues is crucial for the full development of their virulence in the event of infection. Therefore, in a previous study, two synthetic dimeric derivatives (parallel Dimer 1 and antiparallel Dimer 2) of the AMP Cm-p5 showed specific inhibition of the formation of Candida auris biofilms. Here we show that these derivatives are also dose-dependently effective against de novo biofilms that are formed by the widespread pathogenic yeasts C. albicans and C. parapsilosis. Moreover, the activity of the peptides was demonstrated even against two fluconazole-resistant strains of C. auris. Full article
(This article belongs to the Special Issue Biomolecules in the Treatment of Biofilm-Related Diseases)
Show Figures

Figure 1

Back to TopTop